sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×Ó

ǰÑÔ

²¡¶¾ÐÔ¸ÎÑ×(viral hepatitis)ÊÇÓɶàÖÖ²î±ð¸ÎÑײ¡¶¾ÒýÆðµÄÒ»×éÒÔ¸ÎÔàËðº¦ÎªÖ÷µÄѬȾ²¡ £¬¿É·ÖΪ¼×¡¢ÒÒ¡¢±û¡¢¶¡¡¢Îì¡¢¸ýÁùÖÖÀàÐÍ £¬¸÷ÐÍÖ®¼äÎÞ½»Ö¯ÃâÒß £¬¿Éͬʱ»òÏȺóѬȾ £¬»ìÏýѬȾ»òÖØµþѬȾ £¬Ê¹Ö¢×´¼ÓÖØ ¡£¼×ÐͲ¡¶¾ÐÔ¸ÎÑ׺ÍÎìÐͲ¡¶¾ÐÔ¸ÎÑ×ÒԷ࣭¿ÚÈö²¥ÎªÖ÷ £¬³£¼û·¢ÈÈ¡¢»Æ¾Ò £¬³Ê¼±ÐÔ¾­ÓÉ £¬ÓÐÊýǨÑÓ³ÉÂýÐÔ £»ÒÒÐͲ¡¶¾ÐÔ¸ÎÑ׺ͱûÐͲ¡¶¾ÐÔ¸ÎÑ× £¬¶à¾­ÊäѪ»òÑªÖÆÆ·ÒÔ¼°Ç×½ü½Ó´¥Èö²¥ £¬Ò×ǨÑÓÉú³¤³ÉÂýÐÔÉõÖÁ¸ÎÓ²»¯ £¬ÒÑ֤ʵÒÒÐͺͱûÐ͸ÎÑײ¡¶¾Ñ¬È¾Óë¸Î°©ÓÐÒ»¶¨¹ØÏµ £»¶¡ÐͲ¡¶¾ÐÔ¸ÎÑ×ÐèÒÀÀµÓÚÒÒÐ͸ÎÑײ¡¶¾¶ø±£´æ²¢¸´ÖÆ £¬³£ÓëÒÒÐ͸ÎÑײ¡¶¾³Ê»ìÏýѬȾ»òÔÚÒÒÐ͸ÎÑײ¡¶¾ÑôÐÔµÄÂýÐÔÒҸβ¡³ÌÖÐÖØµþѬȾ ¡£ÏÖÔÚ½¨ÉèµÄ²¡¶¾ÐÔ¸ÎÑ×¶¯ÎïÄ£×ÓÖ÷ÒªÓм×Ð͸ÎÑײ¡¶¾Ä£×Ó¡¢ÒÒÐ͸ÎÑײ¡¶¾Ä£×Ó¡¢±ûÐ͸ÎÑ× ²¡¶¾Ä£×ÓºÍÎìÐ͸ÎÑײ¡¶¾Ä£×Ó ¡£

ÎìÐ͸ÎÑ×(hepatitis E)ÊÇÓÉÓÚѬȾÁËÎìÐ͸ÎÑײ¡¶¾(hepatitis E virus,HEV)Ëùµ¼ÖµÄÒ»ÖÖÑÏÖØµÄ¸ÎÔ༲²¡ ¡£ÎìÐ͸ÎÑײ¡¶¾ÊÇÒ»ÖÖСRNA²¡¶¾ £¬Óë¼×Ð͸ÎÑײ¡¶¾Èö²¥Ñ¬È¾·½·¨ÏàËÆ £¬¶¼ÊÇͨ¹ý·à£­¿Ú;¾¶ £¬Ò²¿ÉÄÜÊÇÓÉÓÚѪҺѬȾ £¬Í¨³ £»áµ¼ÖÂÑÏÖØµÄѬȾ ¡£ÔÝʱûÓÐÕë¹ØÓÚÎìÐ͸ÎÑײ¡¶¾²¢Í¨¹ýFDA Åú×¼µÄÒßÃç ¡£ÎìÐ͸ÎÑ×µÄÖ÷ÒªÖ¢×´Óз¢ÈÈ¡¢Òׯ£ÀÍ¡¢Ê³Óû²»Õñ¡¢¶ñÐÄ¡¢ÍÂÄæ¡¢¸¹Í´¡¢»Æ¾Ò¡¢Ð¡±ã»Æ³à¡¢ÊàŦʹµÈ ¡£Ñ¬È¾ºóéæÃüÂÊԼĪΪ1% £¬µ«Ôи¾Ñ¬È¾»áµ¼Ö±©·¢ÐÔ¸ÎÑ×ÉõÖÁéæÃü £¬ÔÚÍíÆÚÈÑÉïµÄ¸¾Å®ÖÐ £¬éæÃüÂʵִï10%~30% ¡£ÒÑ»¼ÓÐÂýÐÔ¸ÎÔ༲²¡µÄÈËѬȾÎìÐ͸ÎÑ׺ó¿ÉÄܻᵼÖ´úлÔÓÂÒ»òéæÃü ¡£ÏÖÔÚÓÃÓÚ½¨ÉèÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÎïÖÖÖ÷ÒªÓкÚÐÉÐÉ¡¢ºãºÓºï¡¢Ê³Ð·ºï¡¢áõºï¡¢Öí¡¢¾ÞϸÊóµÈ ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎºãºÓºï

¡¾ÔìÄ £»úÖÆ¡¿£º

ÎìÐ͸ÎÑ×Ö÷Òª¾­·à£­¿Ú;¾¶£¨Ïû»¯µÀ£©Èö²¥ £¬ÆäËû;¾¶ÓÐѪҺÈö²¥¡¢±ÊÖ±Èö²¥µÈ ¡£Ê¹ÓÃÎìÐ͸ÎÑ×µÄÈö²¥Ìصã £¬Í¨¹ýÏò¶¯Îï¾²Âö×¢ÉäÎìÐ͸ÎÑ×»¼ÕßÐÂÏÊ´ó±ãÂËÒºµÄÒªÁìÓÕµ¼¶¯Îﱬ·¢ÀàËÆÓÚÈËÀà×ÔȻѬȾÎìÐ͸ÎÑײ¡¶¾ºóµÄ¼²²¡Àú³Ì ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

È¡ÎìÐ͸ÎÑ×»¼Õß¼±ÐÔÆÚ·à±ãÑùÆ· £¬ÒÔ0.1mol/L PBS»º³åÒºÖÆ³É10£¥ÐüÒº £¬¾­ÀëÐÄ¡¢Â˾úºó £¬ÒÔ1.5ml/Ö»¼ÁÁ¿¾­ºóÖ«¾²Âö×¢ÉäºãºÓºï(rhesus monkey) ¡£

¡¾Ä£×ÓÌØµã¡¿£º

ѬȾºóµÚ28Ìì×óÓÒ £¬ALT×îÏÈÉý¸ß £¬1ÖÜÃÜ´ï·åÖµ £¬µÚ18~28Ìì×óÓÒ £¬IgGÑôÐÔ £¬120Ìì»Ö¸´Õý³£ £¬14~32Ìì·ºÆð²¡¶¾ÑªÖ¢ ¡£Ñ¬È¾ºóµÚ7~55Ìì·à±ãÅŶ¾ £¬·à±ãÑùÆ·µç¾µÊӲ쵽27~34nmµÄ²¡¶¾Ñù¿ÅÁ£ ¡£¸Î³¬±¡×éÖ¯ÇÐÆ¬µç¾µÊӲ췢Ã÷¸Îϸ°ûÖÊÖб£´æÎìÐ͸ÎÑײ¡¶¾¾ÞϸµÄ²¡¶¾Ñù¿ÅÁ£ £¬ÏûÈÚ»µËÀµÄµ¨ÄÒÉÏÆ¤Ï¸°ûË鯬Öпɼû³É´ØÈº¼¯ÔÚÒ»ÆðµÄ²¡¶¾¿ÅÁ£ ¡£¸Î²¡ÀíÇÐÆ¬¿ÉÊӲ쵽¸ÎʵÖÊËÉÉ¢»µËÀ £¬´ó×ÚÁܰÍϸ°ûºÍÉÙÁ¿ÖÐÐÔÁ£Ï¸°ûÔîÐÔ½þÈó £¬ÖÐÑë¾²Âö±Ú±»ÆÆË𠣬ÁܰÍϸ°û½þÈó £¬»ã¹ÜÇøÑ×֢ϸ°û½þÈó ¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ÔÚÎìÐ͸ÎÑ×·ÇÈËÀàÁ鳤ÀදÎïÄ£×ÓÖÐ £¬ÎÒ¹úÒ»Ñùƽ³£¶¼½ÓÄɺãºÓºï×÷Ϊ¶¯ÎïÄ£×Ó £¬ºãºÓºïÎìÐ͸ÎÑ×¶¯ÎïÄ£×Ó¿ÉÓÃÓÚÁÙ´²Õï¶Ï¡¢¼²²¡Ô¤·À¡¢ÒßÃçÑз¢ ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÄÏ´óº½ £¬ÅËÄþ £¬ÕލÇí£®ÒÒÐ͸ÎÑ×¶¯ÎïÄ£×ÓÑо¿Ï£Íû. ¶«ÄÏ´óѧѧ±¨£¨Ò½Ñ§°æ£© £¬2012, 31 (4):504-507

2.¹¢¼Ò±¦ £¬ÍõÁá £¬ÖìÓÀºì£®ÊµÑéѬȾÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÖйúÔ¤·ÀҽѧÔÓÖ¾ £¬2010, 11(4):429-432

3.Õ²ÃÀÔÆ £¬Áõ³ç°Ø £¬Àî³ÉÃ÷ £¬µÈ£®¼×Ð͸ÎÑײ¡¶¾Ñ¬È¾Ê÷üšµÄÆðÔ´Ñо¿£®Öйúҽѧ¿ÆÑ§ÔºÑ§±¨ £¬1981, 3 (3):148-152

4.Amado LA, Marchevsky RS,de Paula VS, el al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularÐÄ£ºevidence of active exlranepaticsite of HAV replication.Int J Exp Pathol, 2010, 91 (1):87-97

5.Dand.ri M, Burda MR, Torok E, et al. Repopulation of mouse Liver with human hepatocytes and in vivo infection wilh hepatilis B virus. Hepatology, 2001, 33 (4):981-988

6.Dorner M,Horwilz JA,Robbins JB,el al. A genetically humanized mouse model for hepatitis C virus Infection.Nature,2011,474(7350):208-211

7.Maneeral. Y, Clayson ET, Myint KS, et al. Experimental infection of the lahoratory rat with the hepatitis e virus. J Med Virol, 1996,48 (2): 121-128

8.Purcell RH, Emerson SU. Emerson. Animal Models of Hepatitis A and E. ILAR J, 2001, 42 (2): 161-177

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×Ó
ÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×Ó

ǰÑÔ

²¡¶¾ÐÔ¸ÎÑ×(viral hepatitis)ÊÇÓɶàÖÖ²î±ð¸ÎÑײ¡¶¾ÒýÆðµÄÒ»×éÒÔ¸ÎÔàËðº¦ÎªÖ÷µÄѬȾ²¡ £¬¿É·ÖΪ¼×¡¢ÒÒ¡¢±û¡¢¶¡¡¢Îì¡¢¸ýÁùÖÖÀàÐÍ £¬¸÷ÐÍÖ®¼äÎÞ½»Ö¯ÃâÒß £¬¿Éͬʱ»òÏȺóѬȾ £¬»ìÏýѬȾ»òÖØµþѬȾ £¬Ê¹Ö¢×´¼ÓÖØ ¡£¼×ÐͲ¡¶¾ÐÔ¸ÎÑ׺ÍÎìÐͲ¡¶¾ÐÔ¸ÎÑ×ÒԷ࣭¿ÚÈö²¥ÎªÖ÷ £¬³£¼û·¢ÈÈ¡¢»Æ¾Ò £¬³Ê¼±ÐÔ¾­ÓÉ £¬ÓÐÊýǨÑÓ³ÉÂýÐÔ £»ÒÒÐͲ¡¶¾ÐÔ¸ÎÑ׺ͱûÐͲ¡¶¾ÐÔ¸ÎÑ× £¬¶à¾­ÊäѪ»òÑªÖÆÆ·ÒÔ¼°Ç×½ü½Ó´¥Èö²¥ £¬Ò×ǨÑÓÉú³¤³ÉÂýÐÔÉõÖÁ¸ÎÓ²»¯ £¬ÒÑ֤ʵÒÒÐͺͱûÐ͸ÎÑײ¡¶¾Ñ¬È¾Óë¸Î°©ÓÐÒ»¶¨¹ØÏµ £»¶¡ÐͲ¡¶¾ÐÔ¸ÎÑ×ÐèÒÀÀµÓÚÒÒÐ͸ÎÑײ¡¶¾¶ø±£´æ²¢¸´ÖÆ £¬³£ÓëÒÒÐ͸ÎÑײ¡¶¾³Ê»ìÏýѬȾ»òÔÚÒÒÐ͸ÎÑײ¡¶¾ÑôÐÔµÄÂýÐÔÒҸβ¡³ÌÖÐÖØµþѬȾ ¡£ÏÖÔÚ½¨ÉèµÄ²¡¶¾ÐÔ¸ÎÑ×¶¯ÎïÄ£×ÓÖ÷ÒªÓм×Ð͸ÎÑײ¡¶¾Ä£×Ó¡¢ÒÒÐ͸ÎÑײ¡¶¾Ä£×Ó¡¢±ûÐ͸ÎÑ× ²¡¶¾Ä£×ÓºÍÎìÐ͸ÎÑײ¡¶¾Ä£×Ó ¡£

ÎìÐ͸ÎÑ×(hepatitis E)ÊÇÓÉÓÚѬȾÁËÎìÐ͸ÎÑײ¡¶¾(hepatitis E virus,HEV)Ëùµ¼ÖµÄÒ»ÖÖÑÏÖØµÄ¸ÎÔ༲²¡ ¡£ÎìÐ͸ÎÑײ¡¶¾ÊÇÒ»ÖÖСRNA²¡¶¾ £¬Óë¼×Ð͸ÎÑײ¡¶¾Èö²¥Ñ¬È¾·½·¨ÏàËÆ £¬¶¼ÊÇͨ¹ý·à£­¿Ú;¾¶ £¬Ò²¿ÉÄÜÊÇÓÉÓÚѪҺѬȾ £¬Í¨³ £»áµ¼ÖÂÑÏÖØµÄѬȾ ¡£ÔÝʱûÓÐÕë¹ØÓÚÎìÐ͸ÎÑײ¡¶¾²¢Í¨¹ýFDA Åú×¼µÄÒßÃç ¡£ÎìÐ͸ÎÑ×µÄÖ÷ÒªÖ¢×´Óз¢ÈÈ¡¢Òׯ£ÀÍ¡¢Ê³Óû²»Õñ¡¢¶ñÐÄ¡¢ÍÂÄæ¡¢¸¹Í´¡¢»Æ¾Ò¡¢Ð¡±ã»Æ³à¡¢ÊàŦʹµÈ ¡£Ñ¬È¾ºóéæÃüÂÊԼĪΪ1% £¬µ«Ôи¾Ñ¬È¾»áµ¼Ö±©·¢ÐÔ¸ÎÑ×ÉõÖÁéæÃü £¬ÔÚÍíÆÚÈÑÉïµÄ¸¾Å®ÖÐ £¬éæÃüÂʵִï10%~30% ¡£ÒÑ»¼ÓÐÂýÐÔ¸ÎÔ༲²¡µÄÈËѬȾÎìÐ͸ÎÑ׺ó¿ÉÄܻᵼÖ´úлÔÓÂÒ»òéæÃü ¡£ÏÖÔÚÓÃÓÚ½¨ÉèÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÎïÖÖÖ÷ÒªÓкÚÐÉÐÉ¡¢ºãºÓºï¡¢Ê³Ð·ºï¡¢áõºï¡¢Öí¡¢¾ÞϸÊóµÈ ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎºãºÓºï

¡¾ÔìÄ £»úÖÆ¡¿£º

ÎìÐ͸ÎÑ×Ö÷Òª¾­·à£­¿Ú;¾¶£¨Ïû»¯µÀ£©Èö²¥ £¬ÆäËû;¾¶ÓÐѪҺÈö²¥¡¢±ÊÖ±Èö²¥µÈ ¡£Ê¹ÓÃÎìÐ͸ÎÑ×µÄÈö²¥Ìصã £¬Í¨¹ýÏò¶¯Îï¾²Âö×¢ÉäÎìÐ͸ÎÑ×»¼ÕßÐÂÏÊ´ó±ãÂËÒºµÄÒªÁìÓÕµ¼¶¯Îﱬ·¢ÀàËÆÓÚÈËÀà×ÔȻѬȾÎìÐ͸ÎÑײ¡¶¾ºóµÄ¼²²¡Àú³Ì ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

È¡ÎìÐ͸ÎÑ×»¼Õß¼±ÐÔÆÚ·à±ãÑùÆ· £¬ÒÔ0.1mol/L PBS»º³åÒºÖÆ³É10£¥ÐüÒº £¬¾­ÀëÐÄ¡¢Â˾úºó £¬ÒÔ1.5ml/Ö»¼ÁÁ¿¾­ºóÖ«¾²Âö×¢ÉäºãºÓºï(rhesus monkey) ¡£

¡¾Ä£×ÓÌØµã¡¿£º

ѬȾºóµÚ28Ìì×óÓÒ £¬ALT×îÏÈÉý¸ß £¬1ÖÜÃÜ´ï·åÖµ £¬µÚ18~28Ìì×óÓÒ £¬IgGÑôÐÔ £¬120Ìì»Ö¸´Õý³£ £¬14~32Ìì·ºÆð²¡¶¾ÑªÖ¢ ¡£Ñ¬È¾ºóµÚ7~55Ìì·à±ãÅŶ¾ £¬·à±ãÑùÆ·µç¾µÊӲ쵽27~34nmµÄ²¡¶¾Ñù¿ÅÁ£ ¡£¸Î³¬±¡×éÖ¯ÇÐÆ¬µç¾µÊӲ췢Ã÷¸Îϸ°ûÖÊÖб£´æÎìÐ͸ÎÑײ¡¶¾¾ÞϸµÄ²¡¶¾Ñù¿ÅÁ£ £¬ÏûÈÚ»µËÀµÄµ¨ÄÒÉÏÆ¤Ï¸°ûË鯬Öпɼû³É´ØÈº¼¯ÔÚÒ»ÆðµÄ²¡¶¾¿ÅÁ£ ¡£¸Î²¡ÀíÇÐÆ¬¿ÉÊӲ쵽¸ÎʵÖÊËÉÉ¢»µËÀ £¬´ó×ÚÁܰÍϸ°ûºÍÉÙÁ¿ÖÐÐÔÁ£Ï¸°ûÔîÐÔ½þÈó £¬ÖÐÑë¾²Âö±Ú±»ÆÆË𠣬ÁܰÍϸ°û½þÈó £¬»ã¹ÜÇøÑ×֢ϸ°û½þÈó ¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ÔÚÎìÐ͸ÎÑ×·ÇÈËÀàÁ鳤ÀදÎïÄ£×ÓÖÐ £¬ÎÒ¹úÒ»Ñùƽ³£¶¼½ÓÄɺãºÓºï×÷Ϊ¶¯ÎïÄ£×Ó £¬ºãºÓºïÎìÐ͸ÎÑ×¶¯ÎïÄ£×Ó¿ÉÓÃÓÚÁÙ´²Õï¶Ï¡¢¼²²¡Ô¤·À¡¢ÒßÃçÑз¢ ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÄÏ´óº½ £¬ÅËÄþ £¬ÕލÇí£®ÒÒÐ͸ÎÑ×¶¯ÎïÄ£×ÓÑо¿Ï£Íû. ¶«ÄÏ´óѧѧ±¨£¨Ò½Ñ§°æ£© £¬2012, 31 (4):504-507

2.¹¢¼Ò±¦ £¬ÍõÁá £¬ÖìÓÀºì£®ÊµÑéѬȾÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÖйúÔ¤·ÀҽѧÔÓÖ¾ £¬2010, 11(4):429-432

3.Õ²ÃÀÔÆ £¬Áõ³ç°Ø £¬Àî³ÉÃ÷ £¬µÈ£®¼×Ð͸ÎÑײ¡¶¾Ñ¬È¾Ê÷üšµÄÆðÔ´Ñо¿£®Öйúҽѧ¿ÆÑ§ÔºÑ§±¨ £¬1981, 3 (3):148-152

4.Amado LA, Marchevsky RS,de Paula VS, el al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularÐÄ£ºevidence of active exlranepaticsite of HAV replication.Int J Exp Pathol, 2010, 91 (1):87-97

5.Dand.ri M, Burda MR, Torok E, et al. Repopulation of mouse Liver with human hepatocytes and in vivo infection wilh hepatilis B virus. Hepatology, 2001, 33 (4):981-988

6.Dorner M,Horwilz JA,Robbins JB,el al. A genetically humanized mouse model for hepatitis C virus Infection.Nature,2011,474(7350):208-211

7.Maneeral. Y, Clayson ET, Myint KS, et al. Experimental infection of the lahoratory rat with the hepatitis e virus. J Med Virol, 1996,48 (2): 121-128

8.Purcell RH, Emerson SU. Emerson. Animal Models of Hepatitis A and E. ILAR J, 2001, 42 (2): 161-177

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿